Results 221 to 230 of about 6,547,471 (339)

ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors [PDF]

Luciano Gastón Morosi, Giulia Maria Piperno, Lucía López, Roberto Amadio, Sonal Joshi, Alessandra Rustighi, Giannino Del Sal, Federica Benvenuti   +7 more
openalex   +1 more source

CD8⁺ PD-1⁺ T-cells and PD-L1⁺ circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance? [PDF]

, 2019
Αthanasios Kotsakis, Galatea Kallergi, Despoina Aggouraki, Zaharoula Lyristi, Filippos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Vassilis Georgoulias, Eleni‐Kyriaki Vetsika   +8 more
openalex   +1 more source

Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum. [PDF]

NPJ Precis Oncol
Breen KE, Mehta N, Ravichandran V, Mehine M, Gao C, Fiala E, Mukherjee S, Gao M, Arora K, Kemel Y, Roth S, Arnold AG, Kennedy J, Sheehan M, Murphy F, Ptashkin R, Lin A, Walsh M, Ceyhan-Birsoy O, Tap WD, Rolston V, Murciano-Goroff YR, Latham A, Stadler ZK, Offit K, Mandelker D.   +25 more
europepmc   +1 more source

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source

Nanomedicine hitchhiking on bacteria for treating tumors [PDF]

Shujing Zheng, Xingwei Li, Shutao Guo
openalex   +1 more source

Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival

, 2022
Hunter A. Miller, N. Shesh, Xinmin Yin, Xiang Zhang, Jason Chesney, Victor H. van Berkel, Hermann B. Frieboes   +6 more
openalex   +2 more sources

SOX2 is a dispensable modulator of NUT carcinoma oncogenesis in mice. [PDF]

Life Sci Alliance
Luo C, Zheng D, Elnegiry A, Bhatara S, Mias GI, Tsoi MF, Yu J, Gu B.   +7 more
europepmc   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Overcoming barriers in primary bone cancer: Nanomaterial-enabled immunotherapy. [PDF]

Mater Today Bio
Liu Z, Fan L, Wang Y, Zhuo X, Yu D.
europepmc   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source